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Abstract
Background: Given the increasingly stressful environment due to manpower shortages in the
healthcare system in general, substance induced impairment among some healthcare professions is
anticipated to grow. Though recent studies suggest that the prevalence of substance abuse is no
higher in healthcare professionals (HPs) than the general population, given the responsibility to the
public, any impairment could place the public at increased risk for errors. Few studies have ever
reported predictors or risk factors for alcohol and other drug use (AOD) across a sample of HPs.
Methods: The study used a cross-sectional, descriptive self-report survey in a small northeastern
state. A 7-page survey was mailed to a stratified random sample of 697 dentists, nurses, pharmacists
and physicians registered in a northeastern state. The main outcome measures were demographic
characteristics, lifetime, past year and past month prevalence of AOD use, the frequency of use,
drug related dysfunctions, drug misuse and abuse potential. Six contacts during the summer of 2002
resulted in a 68.7% response rate (479/697).
Results: Risk factors contributing to any reported past year AOD use, as well as significant
(defined as the amount of AOD use by the top 25% of respondents) past year AOD use by HPs
were examined using logistic regression. Risk factors of any self-reported past year AOD use
included moderate or more frequency of alcohol use, being in situations when offered AODs,
feeling immune to the addictive effects of drugs (pharmaceutical invincibility) and socializing with
substance abusers. Risk factors of significant past year AOD use were HPs with younger licensees,
a moderate pattern of alcohol use and not socializing with substance abusers.
Conclusion: National and state organizations need to develop policies that focus on prevention,
treatment, and rehabilitation of alcohol and other drug-using healthcare professionals. The results
of this study may help to delineate the characteristics of HPs abusing drugs, leading to the
development of more effective policies designed to protect the public, and move toward more
tailored and effective intervention strategies for HPs.
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Background
The pathways toward development of substance abuse
and dependence problems in healthcare professionals
(HPs) vary by group. For example, though professionally
discouraged, self-diagnosing physicians have reported
prescribing controlled substances for themselves [1]. Due
to drug access, a significant number of pharmacists tend
to self-medicate and have the opportunity to titrate their
drug use [2], a practice that can perpetuate the fallacy that
pharmacological knowledge of drug action is an effective
strategy to prevent addiction. In addition to drug access
and a social environment promoting drug use [3] people
who choose nursing as a profession may report a higher
rate of family history of alcoholism and drug abuse than
other HP groups [4]. Finally, perhaps more so than any
other group of HPs, the greatest threat in dentistry may be
alcohol consumption not controlled substance use [5].
Given the increasingly stressful environment due to man-
power shortages in the healthcare system in general, sub-
stance induced impairment among some healthcare
professions is anticipated to grow [6]. While a number of
studies provide some foundation for our understanding
of the epidemiologic and etiologic processes contributing
to substance use by HPs, rarely have recent studies sought
to examine the relative importance of risk factors on alco-
hol and drug (AOD) use across a sample of major groups
of HPs. The major aim of this study therefore was to inves-
tigate the risk factors contributing to AOD use by HPs
within the context of self-reported past year alcohol and
drug use at different levels of use: any alcohol and drug
use and a substantial level of alcohol and drug use. Early
identification is essential as patient and provider well-
being may be at risk [7]. Just like evidence for alcohol [8],
cocaine [9], and illicit drugs [10], drug dependent HPs
represent a specific subtype of drug abuser who have
access to licit drugs. Knowing those HPs who may be at
greatest risk for substance abuse, may facilitate the devel-
opment of more tailored and effective educational and
intervention strategies for this subtype of addict.
Method
Sample
The study was approved by the University of Rhode Island
Institutional Review Board. Guidelines for sampling were
based on each profession's size in the targeted population:
a northeastern state [11]. The sample was drawn from lists
for each profession supplied by the state Department of
Health during 2002 and was stratified by zip codes to be
representative of all regions of the state. All HPs currently
licensed by and living in the surveyed state, as well as two
closely adjoining states, were eligible.
Based on the population of each HP group in the state,
random sampling of HPs consisted of a process of choos-
ing every "nth" person on each group's list. The sample
frame was 671 for dentists, 1369 for pharmacists, 3424 for
physicians and 15,181 for nurses. The total anticipated to
obtain the targeted final sample of HCPs was 748, consist-
ing of 178 dentists, 188 nurses, 186 pharmacists and 196
physicians (95% confidence level with ± 10% sampling
error).
Survey Administration
During the summer of 2002, using validated self-report
mail survey methods [11] participants chosen from the
sample frame were sent an introductory letter explaining
the purpose of the survey. Beginning at regular, specified
intervals over an eight-week period, participants were
mailed a consent form, cover letter, seven-page survey,
materials to return the survey and to maintain confidenti-
ality – a postcard to be mailed separately from the survey
to remove participants from future contacts. As a token of
appreciation, one dollar was sent to all participants in the
first wave of surveys. After the introductory letter, receipt
of three surveys and two follow-up postcards were possi-
ble, with subsequent mailings going only to non-respond-
ents from previous mailings. The final survey mailed to
the remaining non-respondents was made by priority
mail.
The Questionnaire
The items used in the current study and part of a larger sur-
vey, drew on earlier surveys of HPs [12,13]. A set of 12
items assessed demographic information including pro-
fession, area and specialty of practice, gender, race, ethnic-
ity, current employment, income, marital status and age.
Categorizations delineated below were based on those
used in previous studies and were retained for compara-
bility [12,13]. Respondents were asked to report their reg-
ular number of drinks per day consumed and number of
days per week of alcohol use during the past year and
extrapolated into a 30-day alcohol use index.
Substances assessed in addition to alcohol included,
tobacco (quantity and frequency), legal medications such
as stimulants (e.g. amphetamine and methylphenidate),
major opiates (e.g. methadone, hydromorphone, fenta-
nyl, meperidine, morphine, and oxycodone), minor opi-
ates (e.g. hydrocodone, pentazocine and codeine),
anxiolytics (e.g. alprazolam), sedative-hypnotics (e.g.
zolpidem and temazepam), inhalants (e.g. nitrous oxide
and amyl nitrate), and tranquilizers (e.g. phenobarbital
and ketamine). Two drugs, heroin and steroids, assessed
in much larger samples have provided little data in view
of very low base rates [13] and were not assessed. To pro-
vide general familiarity, trade names rather than generic
terms were used as examples of drugs within each drug
class. "Street" drugs assessed included marijuana, cocaine
(composite analyses considered cocaine a prescriptionSubstance Abuse Treatment, Prevention, and Policy 2008, 3:3 http://www.substanceabusepolicy.com/content/3/1/3
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drug), psychedelics (e.g. lysergic acid diethylamide, mes-
caline and phencyclidine), designer drugs (e.g. methylen-
edioxymethylamphetamine, gamma hydroxybutyrate,
rohypnol, and methamphetamine). Regular use for a drug
other than alcohol was defined as use greater than 11
times during the past year or once per month or more [1].
Pattern of alcohol use
Consistent with previous research, one question assessing
type of drinking pattern asked, "I consider myself a:"
Responses were, "non-drinker," "infrequent drinker,"
"light drinker," "moderate drinker," "heavy drinker," and
"problem drinker."
Family history of alcohol and drug use
A set of two items were hypothesized to measure family
history of alcohol and drug abuse. These measures were
adapted from the short MAST [14] and were previously
reported in greater detail [15]. In addition to no family
members affected, information regarding alcohol and
drug abuse problem-history was requested for eight close
family members: father, mother, sister, brother, grandfa-
ther, grandmother, uncle and aunt [16].
Professional invincibility
One item was hypothesized to measure attitudes towards
one's ability to self-medicate without becoming addicted,
for example the question asked "Please indicate your
degree of confidence that your pharmacotherapeutic
(pharmacodynamic and pharmacological) knowledge
assures that you would never become addicted to medica-
tions or drugs." Response options consisted of a six-point
Likert scale from "Not confident at all" to "Totally confi-
dent" and "Undecided" (not included in analysis). Two
other items assessed how strongly participants believed
self-medication to stay on the job, or function at home,
was an acceptable practice. For example one question
asked, "Please indicate how strongly do you agree or disa-
gree that it is appropriate to take non-prescribed control-
led prescription medication to function at work?" (e.g.,
you have a bad cough and take a codeine type cough
syrup, or hurt your back and take a narcotic analgesic to
keep working etc.). A six-point Likert scale provided
response options. Coefficient alpha was .23 for these three
items. Eliminating one variable (item 1) would increase α
to a maximum of .31. DeVellis [17], Stevens [18] and
Comrey [19] suggest a minimum alpha of .6 to .8. Fur-
thermore, as recommended by Clark and Watson [20] the
inter-class correlations could not pass the .15 barrier that
they recommend. While the scale was not used – an indi-
vidual item (the first) was used in the logistic regression
analysis.
Internal religiosity
Internal religiosity assessed the internal aspect of negative
proscriptions related to religion [3,21], and was a set of
five items. Internal consistency for this scale was α = .89.
For example, one question asked, "Religion gives me a
great amount of comfort and security in life." Respond-
ents scoring highly on internal religiosity would be
expected to use less if any drugs.
Social networks
Adapted from Trinkoff et al. [3], this set of three questions
assessed the external aspect of negative proscriptions and
asked, "Do you personally know anyone, (other than
patients or clients) who (a) drinks heavily or has an alco-
hol problem (b) uses illicit street drugs or (c) uses pre-
scription drugs on his/her own?" Responses for each
question included "spouse or partner," "friend," "cow-
orker or colleague," or "other." Two experts in the Trinkoff
et al. [3] study validated the original items for content,
however no internal consistency data were provided. As
family histories of alcohol and drug use were assessed sep-
arately, "parent" was deleted as a response from this meas-
ure. Respondents were asked to check all that apply. The
range of scores were from 0 (no substance users in social
network) to 3 (know someone who uses all three catego-
ries of substances).
Drug access
Drug access was operationalized as workplace access to
controlled substances. Four questions assessed the availa-
bility of Class II through V controlled substances, non-
controlled prescription medications and of street drugs.
Brand names of drugs for recognition purposes were used
when possible. For example, participants were asked to
respond to the phrase "During the past year: if I really
wanted to get C-2 medications (e.g. Percocet, fentanyl,
morphine, Oxycontin etc.) inappropriately I could have."
A Likert scale with response options ranging from
Strongly disagree to Strongly agree was provided. Coeffi-
cient alpha for these four items was .82.
Negative proscriptions
An index was made comprised of religiosity, social net-
works and drug access [3]. Internal religiosity was recoded
so that higher scores reflected lower religiosity. The three
items were then summed for an index. Consistent with
Trinkoff et al. [3] higher scores on this index would be at
greater risk for drug use than lower scores.
Protective beliefs
Consistent with previous research in this area [22,23],
four items generated by the author considered how
strongly participants feared either the ethical, legal, social,
or moral repercussions of being caught inappropriately
using medications or drugs, or a participants fear of phys-Substance Abuse Treatment, Prevention, and Policy 2008, 3:3 http://www.substanceabusepolicy.com/content/3/1/3
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ical-mental reactions to taking mediations or drugs. For
example one question asked, "Do you agree or disagree
that you fear the legal repercussions of being caught inap-
propriately using medications or drugs." Coefficient alpha
for this scale was .94.
Professional and social influences
A set of three questions assessed the impact of "active"
social influences on alcohol and illicit use of legal medi-
cations. Two of these items were hypothesized to measure
these "active" social influences. These are situations in
which offers of alcohol are made by friends or colleagues
(items adapted from Graham et al [24], Wood et al. [25],
and seminars offering alcohol supported by pharmaceuti-
cal companies and a decision to accept or deny the offer is
made spontaneously. In addition, one question assessed
the effects of active social influences involved with the
illicit use of legal medications [22]. In general, partici-
pants were asked to respond with regard to how many
times in the past year they had been in situations in which
they were either given, bought or offered either a drink by
friends and colleagues or salespeople, or offered prescrip-
tion substances without asking for them. Specifically one
question asked for example, "How many times in the past
year has a friend given, bought, or offered you an alco-
holic beverage." Respondents were provided five-point
Likert response options ranging from "Never" to "10 or
more times." Four questions of interest assessed profes-
sional influences and were based on a question used pre-
viously [26], with additional items generated by the
researcher, and were designed to assess peripheral profes-
sional job-related social influences during the past year.
An example of one question was, "How many times dur-
ing the past year have you been asked for psychoactive
prescriptions (or medications) by colleagues or non-
patients?" Coefficient alpha for the seven items from the
social and professional subscales was .71. A separate scale
removing the two alcohol questions resulted in an alpha
= .62.
Data Analyses
Data analyses were carried out using the Statistical Analy-
sis System (SAS Institute, Cary, NC). The initial phase con-
sisted of distribution analyses and variable formation for
further analysis. With the exception of demographics or
discrete variables, mean substitution was used to replace
missing values [27] as standard deviations were ubiqui-
tously small (SD < 1.0). Variables used in analyses in this
study met guidelines for skew and kurtosis [27].
Because the survey was returned anonymously there was
no way to examine direct differences between those who
responded and those who did not. However, to assess
response bias and if there was any relationship between
various substance use measures and when (which wave)
the survey was returned, the data were examined using
logistic regression, analyses of variance (ANOVA) and
bivariate correlations for lifetime drug use as a function of
wave of data. These methods assume that wave three
responders are more characteristic of non-responders than
are those respondents to the first wave of surveys. There
would be a bias toward lower estimates of substance use
if that were the case. In other words, if substance users
were less likely to respond, then the third wave respond-
ents would have a higher proportion of substance
users[28,29]. First, logistic regression was used to assess
the adjusted odds ratios of several predictor variables
regressed on early responders from wave one of the survey
versus late responders first from wave two then wave three
assuming good model fit [30]. The variables used in the
models were total weekly alcohol use, lifetime frequency
of occasions to drink five or more alcoholic drinks at one
time, lifetime use of minor opiates, gender, alcohol and
drug problems, treatment, and active practice of a religion
were regressed on early versus late responders. The varia-
bles chosen represented significant reported HP behaviors
of interest in this study. Analyses showed that there was a
lack of model fit criteria, suggesting that these variables
were not good predictors of early versus late return. Next,
a series of wave by ANOVAs were conducted on these
same measures. These analyses revealed there were no sig-
nificant differences of the occurrences in any of these var-
iables by wave. Finally, when the survey was returned
(wave) was examined as a bivariate correlation with life-
time drug use episodes that were re-coded as the median
for each response category and then summed (with a
value of 75 times assigned to each drug use category of
">61.") For all HPs combined, the correlation between
wave the survey was returned and drug use was non-signif-
icant (r = .01). For dentists, while non-significant (p =
.08), there was a trend that number of episodes of drug
use was associated with a earlier response (r = -.17). For
nurses, pharmacists and physicians, the number of epi-
sodes of drug use was non-significantly correlated with a
later response (r = .14, p = .11), (r = .10, p = .27) and (r =
-.07, p = .49) respectively. Despite the poor model fit asso-
ciated with the logistic regression analyses, the other
methods employed in the current study found little evi-
dence for systematic non-response bias in these data.
To examine the major aim of the study, logistic regression
was used to assess the biopsychosocial factors predicting
past year AOD use. The biopsychosocial model is a theory
that biological, psychological, and social factors all play
significant roles in human functioning in disease or ill-
ness, and that substance abuse, in this case, is a result of
the combination of these factors [31]. The model pro-
poses that biological, psychological, and sociological
spectrums are interconnected. The model represents a dra-
matic shift in focus from disease to health, recognizingSubstance Abuse Treatment, Prevention, and Policy 2008, 3:3 http://www.substanceabusepolicy.com/content/3/1/3
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that psychosocial factors (e.g. beliefs, relationships, stress)
greatly impact illness and disease. More specifically, the
biopsychosocial model suggests that addiction is a brain
disease that may cause personality problems and social
dysfunction and furthermore delineates a clear and accu-
rate distinction between substance use, abuse, and addic-
tion. It also allows the progressive symptoms of addiction
to be readily identified and organized into progressive
stages [31].
Assessed risk factors consisted of biological (family his-
tory of substance use), demographic (gender, age), occu-
pational (drug access) and legal drug use (current cigarette
use). Social factors included exposure to active social
influences, and positive attitudes of drug use by health-
care professionals. Psychological factors included profes-
sional invincibility and protective beliefs. One logistic
regression model assessed predictors of any alcohol and
drug use versus no alcohol and drug use. A second model
assessed risk factors predicting the top 25% of respond-
ents based on total past year alcohol and other drug use,
assumed to be at greatest risk for substance abuse or
dependence. Therefore a composite of drug and alcohol
use was developed in order to distinguish the HPs most
heavily, using drugs and alcohol. Logistic regression,
ANOVA and bivariate correlation examined potential bias
from non-response which was not significant.
Results
Response
After accounting for non-deliverable surveys, the overall
response rate was 68.7% (697/479) after all three waves of
the survey. The highest response rate was from nurses
(73.3%) and the lowest from physicians (63.4%). Except
for a slight over-representation of men in dentistry and
under-representation of men in pharmacy, the response
from the survey was consistent with demographic infor-
mation provided by the state. The mean age for the entire
sample was 47.5 years (SD = 12.5). The age of the sample
ranged from 42.3 years (SD = 10) for nurses, to 51.0 years
(SD = 13.5) for dentists. The sample was mostly White,
92.9%, Non-Hispanic, 92.2%, and married 77.7%. Of
dentists, 57.5 % reported being a Doctor of Dental Medi-
cine (DMD) and 42.5% reported they were a Doctor of
Dental Science (DDS). Most nurses (45.7%) reported they
had graduated from either a diploma program or with an
associate's degree, which were combined as pre-B.S., RNs.
Another third (33.3%) indicated they had obtained a
bachelor's degree, 20.9% reported they had obtained a
master's degree and no one who responded had obtained
a doctorate. Most pharmacists who responded, indicated
that they had graduated with a BS in Pharmacy (75.2%),
9% had obtained a masters degree, 14.2% a PharmD and
another 1.5% a Ph.D. Most physicians (96.2%) who
responded to the survey indicated they were allopathic
physicians (MD) and a few (3.8%) reported they were
osteopathic physicians (DO).
The outcome measure consisted of a combination of past
year drug/medication and past year alcohol use. The out-
come measure was marginally skewed (2.1) and slightly
kurtotic (4.4), but was acceptable without transformation
[27]. This measure was then divided into two dichoto-
mous groups that consisted of either no drug or alcohol
use (n = 167) and any drug or alcohol use (n = 312) and
used for "Model 1." To examine alcohol and drug use at
extreme ends of the continuum, and provide an outcome
measure of substance misuse, the alcohol and drug use
groups were further subdivided into two orthogonal
groups on the basis of use: the bottom 75% (n = 252) and
the top 25% (n = 60) of respondents. In "Model 2" also
called a "contingency ratio model," the bottom 75% were
coded as 0 and the top 25% coded as 1. This scale there-
fore was sensitive to substantial, by comparison, alcohol
use [M = 412.6 drinks per year, SD = 240.5], drug/medica-
tion use or a modest amount of use of all substances com-
bined. It was therefore hypothesized that the top 25% of
respondents would represent those encompassing the
most alcohol and drug/medication involvement in this
sample. The substance use variable without the non-users
was normally distributed. Therefore, regressing the inde-
pendent variables on these two models should provide a
varied perspective on two unique levels of the summative
use of past year alcohol and drugs/medications.
The measures taken together with the concordance rates
of almost 67.5% [Model 1; n = 479, R2 = .24, χ2(5) =
78.46, p = .0001] and 79.8% [Model 2; n = 312, R2= .41,
χ2(6) = 98.42, p = .0001], suggest the predictors did a
sound job of predicting AOD use. The difference between
the full and reduced models for Model 1, χ2 (6) = 10.36,
p > .05, and Model 2, χ2 (5) = 4.5, p > .05, were not signif-
icant, therefore only the significant predictors associated
with the more parsimonious reduced models were
retained for further individual predictor analyses.
To derive the reduced model each predictor was tested
individually and the non-significant predictors were elim-
inated. The significant predictors for Model 1 (no use and/
or any alcohol and or drug/medication use) shown in
Table 1 include professional invincibility, χ2 (1) = 8.09, p
< .01, a moderate or more pattern of alcohol use, χ2 (1) =
13.3, p < .001, professional/social and/or pharmaceutical
offers for alcohol and other drugs, χ2 (1) = 12.44, p < .001,
as well as social networks that involve other known
acquaintances with alcohol, drug or medication use prob-
lems, χ2 (1) = 11.42, p < .001.
Model 2 shown on the right in Table 1 displays the signif-
icant predictors for any versus significant AOD useSubstance Abuse Treatment, Prevention, and Policy 2008, 3:3 http://www.substanceabusepolicy.com/content/3/1/3
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groups. The regression coefficients suggest the net effects
of all other variables, year licensed, χ2 (1) = 5.5, p < .05,
pattern of alcohol use, χ2 (1) = 43.00, p < .001, and social
networks, χ2 (1) = 4.02, p < .05, were statistically signifi-
cant predictors. There was also a strong trend toward sig-
nificance for current cigarette use, χ2 (1) = 3.6, p = .05.
Finally several predictors trended toward significance but
were excluded from both models (see Notes in Table 1).
Discussion
Consistent with literature suggesting the prevalence of
substance use for the general population declines with age
after peaking in young adulthood [32], older HPs were at
half the risk to report using significant levels of AOD use.
Most studies of HPs in treatment suggest an age for sub-
stance related impairment to be middle adulthood and
HPs younger than 35 tend to abuse a combination of
AOD [33]. Knowing that younger HPs are at the most risk
would suggest that professional licensing boards have an
opportunity to broach the subject of non-prescribed drug
use with newly licensed HPs.
The possible relationship between cigarettes and AOD use
is consistent with previous research [34]. Current cigarette
use was shown to be a significant predictor of high-risk
alcohol use in an ambulatory setting [35] and a strong
correlate to AOD use in college students [36]. Addition-
ally, evidence suggests that cigarette smoking is a signifi-
cant risk factor for opioid dependence [37], a drug class of
major concern for HPs [15]. Part of the weakness attribut-
able to this trend toward an association with alcohol and
other drug use lies with the low base rate of cigarette
smoking in general in the healthcare professionals sur-
veyed in this study (n = 18). Without drawing causal con-
clusions however, it may be prudent to intervene with
HPs who continue to smoke despite the obvious health
risks.
A moderate or more pattern of alcohol use was a signifi-
cant predictor for any drug use as well as significant drug
use. Though the link between alcohol and other drug use
is clearly established, that that pattern of alcohol use was
so strongly associated with an increased risk of alcohol
and other drug use in HPs, however was notable. Alterna-
tively such a strong relationship may also be the result of
modest multicollinearity between the two variables (r =
.67).
HPs who strongly disagreed they needed drugs to work
were at significantly less risk to report AOD use during the
past year. Previous findings suggest a strong belief in the
immunity to becoming addicted to drugs by some HPs
that may be instrumental toward decision making to use
drugs [7]. The current study suggests that those who
would not take drugs for instrumental purposes, such as
to stay at work, were less likely to use a substance of any
kind. Contrary to what was expected, however this finding
suggests that pharmaceutical invincibility may not be a
false belief but a valid and real belief system for HPs,
being especially protective in a no use versus use para-
digm.
Social circles and pharmaceutical offers of AOD use was a
significant predictor for the no use versus use model only.
Perhaps social contacts are important for substance use in
general, but not at a significant level of use. Potentially,
normative use of AOD may be facilitated by social rela-
tionships whereas significant use may be characterized by
Table 1: Predictors for Any Past Year (Model 1) and Significant Alcohol and Drug Use (Model 2)
Predictors (IVs) Model 1 (N = 479) Model 2 (N = 312)
B (SE) β Odds Ratio (OR) C.I. B (SE) β Odds Ratio (OR) C.I.
Background Variables
Year licensed - - - .58* (.33) -.21 .47 .3 – .9
Past month cigarette use - - - 1.11^(.59) .16 3.04 1.0 – 9.6
Pattern of alcohol use 3.01*** (.74) .64 20.27 4.8–86.4 3.37*** (.51) .79 29.01 10.6–79.6
Psychological Variable
Professional invincibility -1.43** (.52) -.17 .24 .1 – .7 - - -
Social Variables
Professional/social and/or pharmaceutical 
offers for alcohol and or drug use
1.24*** (.26) .28 3.45 1.1–2.8 - - -
Social circles with known alcohol and drug 
abusers
.57*** (.24) .15 1.77 2.0 – 5.8 -.66* (.33) -.17 .52 .3–1.0
Intercept -.51 (.26) -.51 (.38)
^p = .056, *p ≤ .05, **p ≤ .01, ***p ≤ .001.
Notes: Only significant predictors shown; - = not-significant; Gender, access to drugs in Model 1 and mean income, family history of substance use 
and religious affiliation in Model 2, were trending toward significance but removed from the models. C.I. = Confidence Interval. IVs = Independent 
VariablesSubstance Abuse Treatment, Prevention, and Policy 2008, 3:3 http://www.substanceabusepolicy.com/content/3/1/3
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withdrawing from social relationships. Supporting this
notion is that the odds ratios for knowing others who are
substance abusers (social circles) between the two models
vary from increasing one's chances of any past year sub-
stance use by over three-quarters to decreasing one's risk
for significant substance use by one-half. Such a contrast
is consistent with previous findings noting that substance-
impaired HPs are often loners and become isolated [38].
There is no healthcare professional drug culture. Health-
care professionals may limit their contact with others out
of fear of discovery and rigorously deny problems to
themselves or others.
This study is limited in several ways. Primarily, the com-
posite used to combine alcohol and drug use as a variable
did not allow analysis of the drug and alcohol use by the
top 25% of HPs. These results are most likely affected by
geographic location and may not generalize to areas out-
side of the northeast. A national survey using similar
methodology would help address this bias associated with
regional samples. Additionally, the data presented are
probably a conservative estimate of AOD use by the
respondents in the state. Healthcare professionals are
probably uniquely motivated to under-report drug use in
particular, in light of the fear of the legal repercussions.
The response rate of almost 69% means that over 31% of
respondents did not respond and could contribute to
measurement error due to non-response. However, con-
sidering the sensitive topic, the response rate for the sur-
vey was strongly commensurate with the other studies of
HPs previously noted. Alternatively, this sample was
drawn from a single state, limiting the generalizability to
the greater population of HPs. Moreover, the alcohol pat-
tern measure used in the present study, which was a sub-
jective measure of alcohol use frequency, was as
previously noted, potentially a less specific and broader
measure of alcohol use as well as non-use, resulting in
increased power as a predictor. Recent evidence suggests
that a single question assessing one's pattern of alcohol
use may underestimate alcohol use [39]. This measure
contrasts with the uni-dimensional but more precise
quantity-frequency index also used in the current study,
but was a non-significant predictor. In concert with the
possibility that total amount of alcohol consumed may
not be a useful predictor of alcohol-related problems [40]
surveys of substance use have found [41] that respondents
may report less alcohol (and other substances) use result-
ing in an underestimate of alcohol use; relative to the
broader pattern measure used in the current study. On the
other hand it is also possible the relationship between a
pattern of drinking is quite predictive of perceived prob-
lems as Wood, et al. [42] demonstrated that non-daily
drinkers scored higher on the Alcohol Dependence Scale
than daily drinkers, putatively because non-daily drinkers
perceived intoxication as more impairing due to low tol-
erance associated with their pattern of drinking. This
would putatively explain the strong relationship between
perceived alcohol use considered more than appropriate
and pattern of use, relative to the broad spectrum of pri-
marily non-daily drinking habits of the HCP population.
Despite the limitations, these findings indicate a need to
educate HPs and students regarding substance use and
abuse. People entrust their personal welfare and safety to
those in the health professions. The profession in turn has
an ethical obligation to ensure that its practitioners can
discharge their duties with skill and safety. Policies should
promote early discovery of professionals who overuse
AOD in order to minimize the period of time that patients
are at risk of being harmed.
Various healthcare professional organizations have
worked to shape policy with regard to substance use in
general. For example, the Physician's Leadership on
National Drug Policy [43] is an ad hoc group of physi-
cians with experience in health, medical care, and policy
development. In June 1997, this group developed and
adopted a Consensus Statement on national drug policy
toward illegal drugs that placed a new emphasis on
national drug policy by refocusing on the prevention and
treatment of harmful drug use. This requires reallocating
resources toward drug treatment and prevention, utilizing
criminal justice procedures which are shown to be effec-
tive in reducing supply and demand, and reducing broad
regulations of addiction treatment programs [43].
More specifically, the American Pharmacists Association
[44] as well as American Association of Colleges of Nurs-
ing [45] have worked to adopt and institute policies of
treatment, prevention, and rehabilitation of AOD-using
healthcare professionals. Agencies such as the Drug
Enforcement Administration, state departments of health,
medical boards, state medical associations, and colleges
teaching healthcare professional programs, should also
coordinate discussions among HPs related to AOD use.
Dissemination of information relating to the warning
signs of drug abuse and sources of help for those affected
by AOD should be continual goals of these agencies. In
particular, educational points to highlight include such
factors as the hazards of self-treatment with prescription
drugs no matter how minor or infrequent; alcohol use,
though modest, may still be an initiate of concomitant
substance use by HPs; addiction education is a priority
need for HP students and professionals and confidential
treatment exists and works well for the majority of
addicted HPs [46].Substance Abuse Treatment, Prevention, and Policy 2008, 3:3 http://www.substanceabusepolicy.com/content/3/1/3
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